Clinical Trial Update: Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting completion of a study evaluating vitamin A (retinol) for the treatment of neonatal sepsis and necrotizing enterocolitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis
• Neonatal Sepsis

Drugs mentioned

• Vitamin A (retinol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Sepsis, Necrotizing Enterocolitis | Phase 3 | Status: COMPLETED